Barclays Downgrades bluebird bio to Underweight, Lowers Price Target to $4
Barclays analyst Gena Wang downgrades bluebird bio (NASDAQ:BLUE) from Equal-Weight to Underweight and lowers the price target from $13 to $4.
SVB Leerink Maintains Market Perform on bluebird bio, Lowers Price Target to $10
SVB Leerink analyst Mani Foroohar maintains bluebird bio (NASDAQ:BLUE) with a Market Perform and lowers the price target from $11 to $10.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 147 companies achieved new lows for the year.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning trading, 152 companies set new 52-week lows.
